Prosper Obed Chukwuemeka

Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus

Haruna Isiyaku Umar, Bushra Siraj, Adeola Ajayi et al. · Journal of Genetic Engineering and Biotechnology · 2021 · 52 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery Approaches

Haruna Isiyaku Umar, Adeola Ajayi, Nobendu Mukerjee et al. · Cells · 2022 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics

Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye et al. · Journal of Biomolecular Structure and Dynamics · 2021 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond “Failure to rescue”

Prosper Obed Chukwuemeka, Haruna Isiyaku Umar, Opeyemi Iwaloye et al. · Journal of Biomolecular Structure and Dynamics · 2021 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design

Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Femi Olawale et al. · In Silico Pharmacology · 2021 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16